Unique Pharma Primo 100 (Methenolone Enanthate 100mg/ml): Comprehensive Technical Overview
Product Profile & Chemical Foundation
Primo 100 by Unique Pharma provides high-grade Methenolone Enanthate formulated at a concentration of 100 mg per milliliter. Methenolone is a synthetic derivative of Dihydrotestosterone (DHT) featuring a 1-methyl group addition, which increases its metabolic stability in skeletal muscle tissue. Appended with the long-acting Enanthate ester, this compound delivers a steady, controlled release profile into the bloodstream following intramuscular administration.
Renowned for its exceptionally high safety margin and minimal androgenic footprint, Methenolone Enanthate is widely regarded as one of the cleanest anabolic agents available for dry lean muscle retention and metabolic refinement.
- Active Ingredient: Methenolone Enanthate
- Concentration: 100 mg/ml
- Chemical Family: Dihydrotestosterone (DHT) Derivative
- Anabolic / Androgenic Ratio: 88 / 44–57
- Aromatization Rate: 0% (Zero conversion to Estrogen)
- Progestogenic Activity: None
- Elimination Half-Life: ~7 to 10 days
Key Physiological Benefits & Performance Action
1. Zero Estrogenic Activity
Because Methenolone possesses a DHT-derived backbone, it cannot interact with the aromatase enzyme. Users experience complete immunity from estrogenic side effects, such as fluid retention, subcutaneous water storage, high blood pressure from bloat, or gynecomastia.
2. Mild Anti-Estrogenic Behavior & SHBG Regulation
While not a replacement for dedicated aromatase inhibitors, Methenolone exhibits mild intrinsic anti-estrogenic properties. Furthermore, like most DHT derivatives, it binds to Sex Hormone-Binding Globulin (SHBG), increasing the concentration of free, unbound testosterone in circulation when co-administered with other compounds.
3. Immuno-Enhancing & Tissue Quality Gains
Unlike harsh androgenic compounds that put severe stress on systemic health, Methenolone has a historical record in clinical medicine for supporting immune function and nitrogen retention in compromised patients. The physical gains accrued are noted for being dense, lean, and highly retainable post-cycle.
Administration Protocols & Dosage Parameters
Due to its relatively low anabolic rating and clean profile, Methenolone Enanthate requires structured dosing strategies to achieve optimal physical enhancements.
- Male Intermediate Protocol: 300 mg to 500 mg per week (administered in 2 split injections, e.g., Monday and Thursday)
- Male Advanced Protocol: 600 mg to 800 mg per week over a 10 to 14 week cycle duration
- Female Protocol: 50 mg to 100 mg per week (requires careful monitoring for androgenic sensitivity)
- Injection Technique: Deep intramuscular (IM) administration into large muscle groups (gluteal, ventrogluteal, or deltoid regions) using sterile technique.
Associated Risk Profile & Side Effect Considerations
1. Mild Endogenous HPTA Suppression
Compared to heavy compounds like Trenbolone or Testosterone, Methenolone is far less suppressive to the Hypothalamic-Pituitary-Testicular Axis (HPTA) at low-to-moderate doses. However, at performance-enhancing dosages (300mg+ weekly), noticeable suppression of endogenous LH, FSH, and natural testosterone synthesis will still occur.
2. Androgenic Sensitivities (DHT-Related)
Although its overall androgenic rating is low, Methenolone remains a DHT derivative. Individuals genetically susceptible to androgenic side effects may experience mild acne, oily skin, or accelerated male pattern hair loss (androgenetic alopecia).
3. Lipid Profile Impact
While milder than C17-alpha alkylated oral steroids, Primo 100 can alter serum lipids by moderately reducing High-Density Lipoprotein (HDL) and slightly elevating Low-Density Lipoprotein (LDL).
4. Zero Hepatotoxicity
Unlike oral Methenolone Acetate or other 17-aa compounds, the injectable Enanthate ester bypasses first-pass hepatic metabolism, presenting no liver toxicity or hepatic strain.
Ancillary Support & Post-Cycle Therapy (PCT)
- Baseline Hormone Synergy: Running a baseline dosage of exogenous Testosterone (e.g., Test C 250) alongside Primo 100 is recommended for male users to maintain baseline physiological functions reliant on estrogen and testosterone.
- Cardiovascular & Lipid Support: Incorporate 3–5 grams of Omega-3 fatty acids, Citrus Bergamot, and regular aerobic exercise to preserve healthy HDL/LDL cholesterol levels.
- Post-Cycle Therapy (PCT): Approximately 18 to 21 days after the final injection (allowing the Enanthate ester to clear), a 4-week PCT utilizing Selective Estrogen Receptor Modulators (SERMs) like Tamoxifen (Nolvadex) or Clomiphene (Clomid) will restore natural endogenous gonadotropin production.
Core Summary: Key Advantages vs. Clinical Considerations
Primary Advantages:
- Complete absence of estrogenic side effects (no water retention or gynecomastia)
- Exceptional lean tissue preservation during strict caloric cutting phases
- Zero liver toxicity (non-17-alpha alkylated injectable)
- Produces high-quality, dense muscle gains with excellent post-cycle retention
- Milder overall impact on blood pressure and health markers compared to heavy anabolics
Clinical Considerations:
- Higher weekly milligram requirement compared to more potent anabolic agents
- Can still cause androgenic side effects like hair thinning in genetically predisposed users
- Causes dose-dependent suppression of natural testosterone synthesis requiring post-cycle therapy
- Long Enanthate ester requires a 3-week clearance period prior to PCT onset
Primo 100 Injectable Unique Pharma
- Brand: Unique Pharma
- Product Code: Unique Pharma
- Availability: In Stock
-
$96.32

